Streetbeat News

Stock Prices

NFLX

Recent options activity for Netflix (NASDAQ:NFLX) shows significant bullish sentiment among big-money traders, with 8 call options and 1 put option. Analysts have mixed ratings, with price targets ranging from $554 to $725. The stock is currently trading at $638.72, down 0.33%.

Portfolio Pulse from Benzinga Insights

May 21, 2024 | 1:46 pm

AMD

GOOG

GOOGL

INTC

META

MSFT

NVDA

QCOM

Nvidia's dominance in AI hardware is being challenged as industry giants support OpenAI's new developer software, Triton, which aims to reduce reliance on Nvidia's Cuda platform. Major companies like Intel, AMD, Qualcomm, Meta, Microsoft, and Alphabet are contributing to this initiative.

Portfolio Pulse from Anusuya Lahiri

May 21, 2024 | 1:44 pm

OZEM

Roundhill Investments has launched the Roundhill GLP-1 & Weight Loss ETF (OZEM), which focuses on the growing weight loss management market. The ETF began trading on Nasdaq and targets the GLP-1 receptor agonists and weight management drugs sector.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:42 pm

MYMD

PMCB

PharmaCyte Biotech (NASDAQ: PMCB) has invested $7 million in MyMD Pharmaceuticals (NASDAQ: MYMD), a clinical stage biopharmaceutical company. This investment aligns with PharmaCyte's strategy to utilize its significant cash position to create additional stockholder value. MyMD has reported positive data from a Phase 2 clinical trial for its lead product, MYMD-1, in sarcopenia.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:41 pm

LYRA

Trading halt status for LYRA was updated at 9:40:00 AM ET. The quotation resumption times and related news are provided.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:40 pm

AZO

AutoZone, Inc. (NYSE:AZO) reported Q3 earnings per share of $36.69, beating expectations, but missed revenue estimates with $4.235 billion. The company cited the timing of tax refunds and cooler weather as factors negatively impacting sales. Despite this, gross profit and operating profit increased, and the company opened 45 new stores. Shares are trading lower by 1.67%.

Portfolio Pulse from Nabaparna Bhattacharya

May 21, 2024 | 1:39 pm

GTBP

GT Biopharma (GTBP) shares have resumed trading after a temporary halt. The company is expected to see increased volatility in the short term as investors react to the news.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:39 pm

RNXT

RenovoRx (NASDAQ: RNXT) announced the publication of pre-clinical studies that support the efficacy and drug delivery mechanism of its TAMP therapy platform. The studies show that TAMP increases intra-arterial pressure, leading to a 100-fold increase in local tissue concentration of the therapy, potentially improving efficacy, safety, and widening the therapeutic window of drugs. The data was published in the Journal of Vascular Interventional Radiology.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:36 pm

JD

JD.com has announced plans to repurchase approximately 14 million ADS shares from certain notes purchasers.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:34 pm

GTBP

GT Biopharma shares were halted on a circuit breaker due to a significant upward movement, with the stock now up 3.97%.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:33 pm